Publications

Publication of research results is a pivotal requirement for a comprehensive improvement of treatment concepts. iOMEDICO supports the international guidelines for transparency and reporting of medical research results.

We regularly present our data at national and international conferences. Our publications are published in scientifically renowned, international journals. Authors are principal investigators, investigators with a high number of participating patients, and scientists of iOMEDICO.

TITEL
STUDIE
JAHR
The treatment of colorectal cancer in German outpatient centres. Data from a clinical registry. A joint project of the AIO and the AKS.

Freier, W., Schröder, J., Rauh, J., Harich, H.-D., Hartmann, H., 2009.

Onkologie 32 (suppl 4)(P197), 47. doi:10.1159/000242462

Abstract

Download

Indikation: Colorectal Cancer, Kolorektalkarzinom / Veranstaltung: DGHO / Journal: Onkologie
TKK
2009
Gemcitabine plus vinorelbine versus gemcitabine plus cisplatin versus gemcitabine plus capecitabine: A randomized trial in pretreated metastatic breast cancer.

Freier, W., Stemmler, H.-J., Tessen, H.-W., Gitsch, G., Jonat, W., Bruger, W., Kettner, E., Tesch, H., Abenhardt, W., Heinemann, V., 2008.

Onkologie 31 (suppl 4)(P470), 164. doi:10.1159/000161588

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: DGHO / Journal: Onkologie
Gemcitabine 02 MC
2008
Quality of life in relation to hormonal treatment of postmenopausal women in the Dutch subset of the TEAM Trial.

van Nes, J., Voskuil, D., Putter, H., van Leeuwen, F., Junggeburt, J., Hille, E., de Haes, H., van de Velde, C., 2008.

Cancer Res 69(2 Supplement), 21. doi:10.1158/0008-5472.SABCS-21

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: SABCS / Journal: Cancer Research
TEAM
2008
Bendamustine versus chlorambucil as first-line treatment in B cell chronic lymphocytic leukemia: An updated analysis from an international phase III study.

Knauf, W.U., Lissitchkov, T., Aldaoud, A., Liberati, A., Loscertales, J., Herbrecht, R., Juliusson, G., Postner, G., Gercheva, L., Goranov, S., Becker, M., Hoeffken, K., Huguet, F., Foa, R., Merkle, K., Montillo, M., 2008.

Blood 112(11), 2091.

Abstract

Indikation: Haemoblastoma, Hämoblastosen / Veranstaltung: ASH / Journal: Blood
02 CLL III
2008
Results of the first planned analysis of the TEAM (tamoxifen exemestane adjuvant multinational) prospective randomized phase III trial in hormone sensitive postmenopausalearly breast cancer.

Jones, S.E., Seynaeve, C., Hasenburg, A., Rea, D., Vannetzel, J.M., Paridaens, R., Markopoulos, C., Hozumi, Y., Putter, H., Hille, E., Kieback, D.G., Asmar, L., Smeets, J., Urbanski, R., Bartlett, J., van de Velde and D Rea, C., 2008.

Cancer Res 69(2 Supplement), 15. doi:10.1158/0008-5472.SABCS-15

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: SABCS / Journal: Cancer Research
TEAM
2008
Bone Effects of Exemestane vs. Tamoxifen within the German TEAM trial: Results of a Prospective Randomized Bone Sub-Study.

Hadji, P., Ziller, M., Kieback, D., Dornoff, W., Tessen, H., Kuck, J., Hasenburg, A., 2008.

Cancer Res 69(2 Supplement), 1143. doi:10.1158/0008-5472.SABCS-1143

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: SABCS / Journal: Cancer Research
TEAM
2008
Colon Registry: Influence of comorbidity on the choice of chemotherapeutic treatment. A joint project of the AIO and the AKS.

Freier, W., Arnold, D., Otremba, B., Marschner, N., 2008.

Onkologie 31 (suppl 4)(P301), 109. doi:10.1159/000161574

Abstract

Download

Indikation: Colorectal Cancer, Kolorektalkarzinom / Veranstaltung: DGHO / Journal: Onkologie
TKK
2008
A prospective planned pathology study within the TEAM trial confirms that progesterone receptor expression is prognostic but not predictive for differential response to exemestane versus tamoxifen.

Bartlett, J., Brookes, C., Billingham, L., Campell, F., Gnant, M., Hasenburg, A., Hille, E., Kay, C., Kieback, D., Markopoulos, C., Meershok-Klein Kranenberg, E., Mallon, E., Paridaens, R., Putter, H., Robson, T., Seynaeve, C., van de Velde and D Rea, C., 2008.

Cancer Res 69 (2 Supplement), 81. doi:10.1158/0008-5472.SABCS-81

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: SABCS / Journal: Cancer Research
TEAM
2008
Bendamustine versus chlorambucil in treatment-naive patients with B-cell chronic lymphocytic leukemia (B-CLL): Results of an international phase III study.

Knauf, W.U., Lissichkov, T., Aldaoud, A., Herbrecht, R., Liberati, A.M., Loscertales, J., Juliusson, G., Dittrich, C., Merkle, K., 2007.

Blood 110(11), 2043.

Abstract

Indikation: Haemoblastoma, Hämoblastosen / Veranstaltung: ASH / Journal: Blood
02 CLL III
2007
Xeloda in Adjuvant Colon Cancer Therapy (X-ACT) trial: overview of efficacy, safety, and cost-effectiveness.

Twelves, C.J., 2006.

Clin Colorectal Cancer 6, 278–287.

Abstract

Indikation: Colorectal Cancer, Kolorektalkarzinom / Veranstaltung: - / Journal: Clinical Colorectal Cancer
X-ACT
2006